To scale or not to scale: the principles of dose extrapolation
about
sameAs
Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality.Neemazal ® as a possible alternative control tool for malaria and African trypanosomiasis?A simple practice guide for dose conversion between animals and humanXenotransplantation models to study the effects of toxicants on human fetal tissuesNon-Invasive In Vivo Imaging and Quantification of Tumor Growth and Metastasis in Rats Using Cells Expressing Far-Red Fluorescence ProteinKetamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSnDried whole plant Artemisia annua as an antimalarial therapyMiltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical StudyScaling and systems biology for integrating multiple organs-on-a-chip.Effects of developmental exposure to polychlorinated biphenyls and/or polybrominated diphenyl ethers on cochlear functionIndocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques.Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic AdenovirusProjecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned?Suboptimal Dosing Parameters as Possible Factors in the Negative Phase III Clinical Trials of Progesterone for Traumatic Brain Injury.What is the right dose for children?New delivery systems to improve the bioavailability of resveratrol.Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers.2-methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques.Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniques.Lefetamine, a controlled drug and pharmaceutical lead of new designer drugs: synthesis, metabolism, and detectability in urine and human liver preparations using GC-MS, LC-MS(n), and LC-high resolution-MS/MS.Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MSn , and LC-HR-MSn.Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs.A physiologically based pharmacokinetic model of alvespimycin in mice and extrapolation to rats and humans.A Multifaceted GABAA Receptor Modulator: Functional Properties and Mechanism of Action of the Sedative-Hypnotic and Recreational Drug Methaqualone (Quaalude)Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokineticsPharmacokinetics of injectable, long-acting nevirapine for HIV prophylaxis in breastfeeding infants.Lycopene and apo-10'-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in β-carotene-9',10'-oxygenase knockout male miceThe antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model.Single oral dose pharmacokinetics of decursin and decursinol angelate in healthy adult men and women.Allometric scaling for chemical restraint in greater rheas (Rhea americana) with tiletamine and zolazepam.Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin 1 activity in mice.Perils of paediatric anaesthesia and novel molecular approaches: An evidence-based review.Pharmacokinetics of long-acting tenofovir alafenamide (GS-7340) subdermal implant for HIV prophylaxis.Applications of human pharmacokinetic prediction in first-in-human dose estimationEvidence supporting the conceptual framework of cancer chemoprevention in canines.An Investigation into the Immunomodulatory Activities of Sutherlandia frutescens in Healthy Mice.Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate Carcinogenesis
P2860
Q22242315-1351028C-8E1D-44FE-8CAD-8705ADDB8C36Q26315488-46B187BC-9688-4EE7-A036-862FDF78B647Q26750843-09F7E7C9-35AF-4E32-A998-4D5C25337C97Q27013024-0E5DD135-FD1F-48EA-8B0E-1B4EC75D88B6Q27302839-84F70F53-AEAC-44CC-9D42-5D5CE050CE56Q28292983-12174587-6A88-4444-88D6-B00760DA635FQ28484494-FA107B64-CCDE-419F-812C-F4BA57358F11Q28551006-923D81A3-D3BA-4D26-9881-2C472BBC9658Q30410626-7818E868-DA1C-4760-9724-D86E131890B9Q30462007-25815375-2C1D-4837-B944-CFDD92A88A97Q30472773-D9E07B31-C845-4357-AB34-252104453F52Q33633287-E1FCEB8B-FC8E-43F6-BE62-20CCEBEABF98Q33723852-65002F59-E8C3-4CBC-83F6-02E9EFC25A32Q33756256-A29512D8-53DE-4231-98FF-FDF794F8397EQ34180493-895A9178-4B98-48A8-9F53-42C606DF418CQ34192059-B0B6CC99-0E2C-4231-B8B2-1935D7FD77B7Q34282732-9FDCBF47-62CD-4C73-9F2F-2BE2554AD537Q34325128-8337F0BC-B680-4878-B55B-2ABEFB9A37C1Q34408021-D836EC1E-A991-4A38-A43D-DB146B3DC31CQ34451894-64237927-9382-4D1C-A624-F2B1488B89C9Q34457560-FE269D73-92DE-4D1C-A514-D542D4AA6A94Q34490537-0B8263FF-B9A6-4865-89EA-5D4D9C89F2C1Q34497670-BC222F18-9EC1-4AE3-9940-A1B20E9EDCB1Q34510789-4564797A-93ED-4C41-A4E3-2E99747534F5Q34543679-36A8E946-D173-4EE3-AC7C-AFECD0880173Q34570770-AA14CB68-B6B8-4336-9559-9DF2C12DA9AEQ34661183-C046CEE2-37AB-4EBB-9E05-2AD5C03F9E3EQ34667775-194E9A4A-8EED-4A0F-BB13-9F7F9395D5E8Q34922985-B3E70C87-29EC-46F9-8596-3C88C2D8AD43Q35004571-6BE32BDB-3E04-450D-9FB0-44001F869C33Q35080134-6D836D3C-78A3-47B4-B899-FAB8339A575AQ35103322-6027E66D-BF10-41C0-AB6F-15FBBA2E262CQ35119572-8E10D917-88AF-4EC0-8A52-2F6C8E653C2CQ35513609-AC373178-00AD-4AA6-8EE8-26A8F1675C54Q35651738-EFD14FFE-AE1E-4747-BF2D-74F3DB3B4E35Q35746114-9A943A7D-AFE4-496D-B75C-02B3C5247BEEQ35888391-70F72CFA-E097-4873-99FD-FE211CFC60FAQ36027286-C6B9B802-D1B6-4FE9-8675-2115F45C565CQ36116696-3B1500CB-D093-4FC3-A0F1-5AFF45C0198FQ36288473-0273D895-D37B-4CDF-ADFE-8233E80D5BB8
P2860
To scale or not to scale: the principles of dose extrapolation
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
To scale or not to scale: the principles of dose extrapolation
@ast
To scale or not to scale: the principles of dose extrapolation
@en
To scale or not to scale: the principles of dose extrapolation
@nl
type
label
To scale or not to scale: the principles of dose extrapolation
@ast
To scale or not to scale: the principles of dose extrapolation
@en
To scale or not to scale: the principles of dose extrapolation
@nl
prefLabel
To scale or not to scale: the principles of dose extrapolation
@ast
To scale or not to scale: the principles of dose extrapolation
@en
To scale or not to scale: the principles of dose extrapolation
@nl
P2860
P3181
P1476
To scale or not to scale: the principles of dose extrapolation
@en
P2093
John H McNeill
Vijay Sharma
P2860
P304
P3181
P356
10.1111/J.1476-5381.2009.00267.X
P407
P577
2009-07-01T00:00:00Z